


Adebiotech Campus ouvre sa 2ème édition à ses 2000 sympathisants, le 25 janvier 2017

Aelix Therapeutics appoints industry expert Philippe Monteyne as independent board member

GPCR: Domain Therapeutics grants Alkermes a non-exclusive license for its BioSens-All™ technology

Minoryx Therapeutics receives European Orphan Drug Designation for its lead candidate MIN-102

PDC*line Pharma raises €4 million ($4.24M) in a first round and appoints Eric Halioua as president and CEO

Biomunex appoints Dr. Amigorena and Dr. Grabulovski as key scientific and strategic advisors

Domain Therapeutics and Medicxi launch Mavalon Therapeutics

Domain Therapeutics, UdeM, IRICoR and McGill University extend agreement on GPCR biosensor technology
